You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
Swing Therapeutics announced it raised $11.4 Million in an initial filing from an offering of $14.6 Million
RECENTLY ACQUIREDAug 29, 2025•about 1 year ago
Amount Raised
$11.4 Million
Round Type
Venture - Series Unknown
San FranciscoBiotechnology
Company Information
Company
Swing Therapeutics
Location
548 MARKET STREET, #63989
San Francisco, California, United States
About
Swing Therapeutics was founded in 2019 with the goal of developing digital treatments and services in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development of prescription-based digital therapies and services. Swing Therapeutics received FDA Breakthrough Device Designation for its digital therapy for fibromyalgia management. Its near-term goal is to validate its digital therapy and bring it to market as an FDA-cleared, prescription digital therapeutic. For more information visit swingtherapeutics.com.
Don't miss Swing Therapeutics's next move
Get an email the moment Swing Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
2 contacts
Verified contactsMike R., Executive Officer, Director hidden
Predictive Intelligence
Strategic
ML-powered predictions for Swing Therapeutics's next move
San FranciscoBiotechnology